logo
Select company
Select metric
$ 4.61MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
27
Sector
48
Industry
60
History
73
$ 3.29Close
$ 0.51 - $ 5.18 52-Week Range
Ticker Information

Ticker

PROK

Company Name

PROKIDNEY CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROKIDNEY CORP - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PROK - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 4.61M
3/31/2025$ 144.46M
12/31/2024$ 144.46M
9/30/2024$ 134.83M
6/30/2024$ 130.36M
3/31/2024$ -9.5M
12/31/2023$ -9.5M
9/30/2023$ 0
6/30/2023$ 548.55M
3/31/2023$ 543M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROKIDNEY CORP's latest trailing twelve months (TTM) CF - Equity stands at $ 252M.
  • Over the past 5 years, PROKIDNEY CORP's average CF - Equity has been $ 202.65M.
  • The median CF - Equity for PROKIDNEY CORP during this period was $ 139.64M
  • PROKIDNEY CORP reached its highest CF - Equity over the past 5 years at $ 548.55M.
  • The lowest CF - Equity recorded by PROKIDNEY CORP in the same timeframe $ -9.5M

PROKIDNEY CORP's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
SEPN : SEPTERNA INC $ 303.23MMREO : MEREO BIOPHARMA GROUP PLC $ -346KABEO : ABEONA THERAPEUTICS INC $ 22.28MCRDF : CARDIFF ONCOLOGY INC $ 51.62MAVTX : AVALO THERAPEUTICS INC $ 69.48MBBOT : BRIDGEBIO ONCOLOGY THERAPEUTICS INC $ -187.2MCOYA : COYA THERAPEUTICS INC $ 9.65MMNMD : MIND MEDICINE (MINDMED) INC $ 75.34MSANA : SANA BIOTECHNOLOGY INC $ 4.32MERNA : ERNEXA THERAPEUTICS INC $ 5.93M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

PROK - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -9.5M

Minimum

Dec 31, 2023

$ 548.55M

Maximum

Dec 31, 2022

$ 202.65M

Average

$ 139.64M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 139.46K with a standard deviation of $ 17.67M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 139.46K
median$ 0
std$ 17.67M